CORDIS
Forschungsergebnisse der EU

CORDIS

Deutsch DE

Hybrid Drug Delivery Systems upon Mesoporous Materials, Self Assembled Therapeutics and Virosomes

Ziel

HYMADE focuses on the development of capsules and engineered colloidal particles for drug delivery combining mesoporous colloids, the Layer by Layer (LbL) technique and virosomes. The capsules and particles have potential applications in cancer and inflammatory diseases such as rheumatoid arthritis and uveitis.
The project is based on the secondments of Early Stage Researchers and Experienced Researchers and networking and training activities between European and non European academic institutions.
HYMADE aims to profit from the combination of hybrid materials to fabricate advanced drug delivery systems with controlled release and targeting efficiency of biological entities. The project also aims to gain understanding of the self assembly process of hybrid materials and the transport properties of the drug delivery systems.The biological fate, drug release, degradation and therapeutical efficiency of the drug delivery systems will be studied in vitro and in vivo with state of the art imaging techniques. To achieve these goals we have gathered an international multidisciplinary team with scientists at the forefront of Material Science, Self assembly, Physics, Chemistry, Biophysics and Imaging from Germany, Austria, France and Spain on the European side and from United States of America, Argentina and Armenia on the non European side.
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Koordinator

ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOMATERIALES- CIC biomaGUNE

Adresse

Paseo Miramon 182, Parque Tecnologico De San Sebastian Edificio Empresarial C
20009 San Sebastian

Spanien

Aktivitätstyp

Research Organisations

EU-Beitrag

€ 747 000

Beteiligte (4)

Alphabetisch sortieren

Nach EU-Beitrag sortieren

Alles aufklappen

AIT AUSTRIAN INSTITUTE OF TECHNOLOGY GMBH

Österreich

EU-Beitrag

€ 243 000

UNIVERSITAET LEIPZIG

Deutschland

EU-Beitrag

€ 157 500

UNIVERSITE PIERRE ET MARIE CURIE - PARIS 6

Frankreich

SORBONNE UNIVERSITE

Frankreich

EU-Beitrag

€ 72 000

Partner (5)

Alphabetisch sortieren

Alles aufklappen

UNIVERSITY OF MICHIGAN THE REGENTS OF THE UNIVERSITY OF MICHIGAN

Yerevan State University

COMISION NACIONAL DE ENERGIA ATOMICA

CONSEJO NACIONAL DE INVESTIGACIONES CIENTIFICAS Y TECNICAS (CONICET)

UNIVERSIDAD NACIONAL DE GENERAL SAN MARTIN

Projektinformationen

ID Finanzhilfevereinbarung: 645686

Status

Abgeschlossenes Projekt

  • Startdatum

    1 Februar 2015

  • Enddatum

    31 Januar 2019

Finanziert unter:

H2020-EU.1.3.3.

  • Gesamtbudget:

    € 1 219 500

  • EU-Beitrag

    € 1 219 500

Koordiniert durch:

ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOMATERIALES- CIC biomaGUNE

Spanien